Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial.

Saved in:
Bibliographic Details
Title: Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial.
Authors: Knowler WC; Biostatistics Center, Milken Institute School of Public Health, George Washington University, Rockville, MD, USA. Electronic address: dppmail@bsc.gwu.edu., Doherty L; Biostatistics Center, Milken Institute School of Public Health, George Washington University, Rockville, MD, USA., Edelstein SL; Biostatistics Center, Milken Institute School of Public Health, George Washington University, Rockville, MD, USA., Bennett PH; National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ, USA., Dabelea D; Lifecourse Epidemiology of Adiposity and Diabetes Center, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Hoskin M; National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ, USA., Kahn SE; Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, WA, USA., Kalyani RR; Division of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Kim C; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA., Pi-Sunyer FX; Departments of Medicine and Epidemiology, Columbia University Irving Medical Center, New York, NY, USA., Raghavan S; Department of Medicine, VA Eastern Colorado Health Care System and University of Colorado School of Medicine, Aurora, CO, USA., Shah VO; School of Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA., Temprosa M; Department of Biostatistics and Bioinformatics and Biostatistics Center, Milken Institute School of Public Health, George Washington University, Rockville, MD, USA., Venditti EM; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Nathan DM; Diabetes Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Corporate Authors: DPP/DPPOS Research Group
Source: The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2025 Jun; Vol. 13 (6), pp. 469-481. Date of Electronic Publication: 2025 Apr 28.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
Journal Info: Publisher: The Lancet, Diabetes & Endocrinology Country of Publication: England NLM ID: 101618821 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-8595 (Electronic) Linking ISSN: 22138587 NLM ISO Abbreviation: Lancet Diabetes Endocrinol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2213-8595
DOI:10.1016/S2213-8587(25)00022-1